topic0
Tumour NOS [neop] 0.00795351524672
Disease-Free Survival [qnco] 0.00295768603607
Treated [ftcn] 0.00276489671565
Higher [qlco] 0.00328661082162
Present [qnco] 0.00265321664026
Imaging, Magnetic Resonance [diap] 0.00335370760733
Survival [acty] 0.0102622784507
Group [idcn] 0.00291476084238
resection [topp] 0.00294030986664
Including [ftcn] 0.00376409354976
CI [geoa] 0.00594069790332
Association [menp] 0.00499192844955
Performed [ftcn] 0.00286086471749
Independent [idcn] 0.00435440605187
LOCAL [spco] 0.00334016421193
Study [mnob] 0.00854430254184
control [qlco] 0.00438861307594
DIAGNOSIS [fndg] 0.00296008723544
ULTRASOUND [diap] 0.00336331421649
Methods [inpr] 0.0069502848189
Enhanced [acty] 0.00419587516014
Risk Factors [qnco] 0.00989355455454
Cases [ftcn] 0.00912621842924
Contrast [irda] 0.00266590063553
included [ftcn] 0.00268055492786
Cholangiocarcinoma [neop] 0.0031337577732
Liver Transplantation [topp] 0.00474924544216
YEAR [tmco] 0.00294959028819
LIVER [bpoc] 0.00344826543314
Conclusions [idcn] 0.00412331605901
Related [qlco] 0.00269029643339
Genotype [orga] 0.00295816943895
CCA [cgab] 0.00472738481012
TIME [tmco] 0.00268770999869
treatment [ftcn] 0.006731353249
CIRRHOSIS [dsyn] 0.002684306737
Detected [fndg] 0.00282719711662
Compared [acty] 0.00450987720011
Tumors [neop] 0.00441882047793
HCC [neop] 0.00356828038735
topic1
Tumour NOS [neop] 0.00322325207144
Treated [ftcn] 0.00379636570867
Higher [qlco] 0.00340446797375
Groups [idcn] 0.00279366600158
Survival [acty] 0.0062135772337
Group [idcn] 0.00464281355166
DIABETES MELLITUS [dsyn] 0.00305633031756
Risk Factors [qnco] 0.0111594698804
CI [geoa] 0.00447087446459
Hazard Ratio [qnco] 0.0038807302058
Fibrosis, Liver [dsyn] 0.00350350831361
Association [menp] 0.00311781571462
Performed [ftcn] 0.00368605396335
HEPATITIS B VIRUS [virs] 0.0030814826628
DIAGNOSIS [fndg] 0.00308362425057
Study [mnob] 0.00746168208606
Mortality [qnco] 0.0033167300944
surveillance [ftcn] 0.00302818133732
Conclusions [idcn] 0.00324896662358
FIBROSIS [patf] 0.00482029265211
CANCER [neop] 0.00417296912441
Cases [ftcn] 0.00448615196441
YEARS [tmco] 0.00657174197229
control [qlco] 0.00313495619649
Cholangiocarcinoma [neop] 0.00372068434967
Liver Transplantation [topp] 0.00571563868149
YEAR [tmco] 0.00379843516024
LIVER [bpoc] 0.00394984889676
Related [qlco] 0.00446457550754
CCA [cgab] 0.00318513763159
Identified [qlco] 0.00282903075765
treatment [ftcn] 0.00415992952432
CIRRHOSIS [dsyn] 0.00636173658431
Methods [inpr] 0.00634471753476
Levels [qlco] 0.00356181286668
Compared [acty] 0.00637683700112
Mice [mamm] 0.00293144771522
Tumors [neop] 0.00332334230949
Increased [qnco] 0.00333462018856
Induced [ftcn] 0.00332267852874
topic2
Median [spco] 0.00307553747308
DIAGNOSIS [fndg] 0.00278293585579
Groups [idcn] 0.00424455127379
Survival [acty] 0.00689618804758
Group [idcn] 0.00436995896568
resection [topp] 0.00535169105715
Based [ftcn] 0.00452393468812
CI [geoa] 0.00925157570615
Hepatic [blor] 0.00391378088571
Liver Cancer [neop] 0.00275982417793
LIVER [bpoc] 0.00901695777907
Performed [ftcn] 0.00273665946971
HEPATITIS B VIRUS [virs] 0.0084074437571
Increased [qnco] 0.00299632779972
Independent [idcn] 0.00384378685582
Study [mnob] 0.00726146271974
Mortality [qnco] 0.00554910313968
Suggest [idcn] 0.00367283351351
Including [ftcn] 0.00377859231345
Nonalcoholic Fatty Liver Disease [dsyn] 0.00558867765855
Methods [inpr] 0.00660086036418
Compared [acty] 0.00401995106521
Cases [ftcn] 0.00327901140363
YEARS [tmco] 0.00561012692268
Index [inpr] 0.00331638253139
YEAR [tmco] 0.00425313539408
Hepatectomy [topp] 0.00413018680039
Conclusions [idcn] 0.00318027282173
Related [qlco] 0.00725592448987
control [qlco] 0.00301459450033
Odds Ratio [qnco] 0.00589175856863
treatment [ftcn] 0.00502465070924
CIRRHOSIS [dsyn] 0.00329580646405
FIBROSIS [patf] 0.00337872293366
Levels [qlco] 0.00364154110531
Risk Factors [qnco] 0.00768406514185
Association [menp] 0.00380472635586
CANCER [neop] 0.00371063642845
Curative [cnce] 0.00409714896632
HCC [neop] 0.00359864442907
topic3
Tumour NOS [neop] 0.00682211286574
Survival [acty] 0.00628015068369
Group [idcn] 0.00652788784956
resection [topp] 0.00655165501853
Based [ftcn] 0.00353631620799
HEPATITIS C VIRUS [virs] 0.00413403530633
Hepatic [blor] 0.00289904993656
Microvascular [ftcn] 0.00352036635224
Hepatectomy [topp] 0.00508940654874
Criteria [inpr] 0.00465109043754
HEPATITIS B VIRUS [virs] 0.00337918917705
Independent [idcn] 0.00316390271186
Invasion [fndg] 0.00503408484515
Study [mnob] 0.00749259052916
included [ftcn] 0.00268206849249
Conclusions [idcn] 0.00365019969109
Nonalcoholic Fatty Liver Disease [dsyn] 0.00404031496426
Methods [inpr] 0.00453525465663
Enhanced [acty] 0.00321516528448
Risk Factors [qnco] 0.00513000390281
Cases [ftcn] 0.00370660695483
Intrahepatic Cholangiocarcinoma [neop] 0.00726911226516
YEARS [tmco] 0.00381292850738
Value [qnco] 0.00286788797005
Liver Transplantation [topp] 0.0147500872723
YEAR [tmco] 0.00306376665591
LIVER [bpoc] 0.00375423471622
RATIO [qnco] 0.00334970704812
Related [qlco] 0.00313947321482
Tumors [neop] 0.00367700160093
treatment [ftcn] 0.00326605839619
CIRRHOSIS [dsyn] 0.00494044159968
Increased [qnco] 0.00282438034938
Liver Cancer [neop] 0.00409544706395
Compared [acty] 0.00541633168611
Pathology [bmod] 0.00275032486355
Performed [ftcn] 0.00295972345705
CANCER [neop] 0.00503025538428
Curative [cnce] 0.00301368459865
HCC [neop] 0.0051191346205
topic4
Tumour NOS [neop] 0.00409378404371
Median [spco] 0.00402841488484
DIAGNOSIS [fndg] 0.00285951998667
Groups [idcn] 0.00399048403644
Survival [acty] 0.012669834037
Group [idcn] 0.0075595499661
resection [topp] 0.00857046952029
CI [geoa] 0.00447257161853
HEPATITIS C VIRUS [virs] 0.0053436290753
Hazard Ratio [qnco] 0.00438866148712
Prognostic [inpr] 0.00287296393252
Microvascular [ftcn] 0.00346341703182
LIVER [bpoc] 0.00318451826083
Independent [idcn] 0.00571215951641
Invasion [fndg] 0.00514839543173
Study [mnob] 0.0112754909871
Mortality [qnco] 0.00336706391872
Evaluate [hlca] 0.00316210786553
Conclusions [idcn] 0.00361025374279
Nonalcoholic Fatty Liver Disease [dsyn] 0.0041635529557
Methods [inpr] 0.00607006615166
Compared [acty] 0.00386237649457
Cases [ftcn] 0.00441551956542
liver resection [topp] 0.00312157287089
YEARS [tmco] 0.00596430376315
Higher [qlco] 0.00322366162238
included [ftcn] 0.00295175358505
YEAR [tmco] 0.00859690455488
Hepatectomy [topp] 0.00342104312943
Related [qlco] 0.0051282134931
Postoperative [tmco] 0.00502713111832
Identified [qlco] 0.00385803992223
treatment [ftcn] 0.00852433491324
CIRRHOSIS [dsyn] 0.00458741882292
Preoperative [tmco] 0.00327009026619
Levels [qlco] 0.00384658631737
Risk Factors [qnco] 0.0111613160269
Association [menp] 0.00281371551508
CANCER [neop] 0.00358188830641
Increased [qnco] 0.00444224943713
topic5
Tumour NOS [neop] 0.0023972275653
HCV [virs] 0.00294271193314
Radiofrequency Ablation [topp] 0.00764478923318
Groups [idcn] 0.00301741017323
Survival [acty] 0.00673658836546
Group [idcn] 0.00402399643053
Based [ftcn] 0.00528113251729
CI [geoa] 0.00304731877841
Hazard Ratio [qnco] 0.00383281824131
Nonalcoholic Steatohepatitis [dsyn] 0.00327025683303
Hepatic [blor] 0.00256578901226
Performed [ftcn] 0.0035699223485
HEPATITIS B VIRUS [virs] 0.00684480378206
SERUM [bdsu] 0.00412218358758
Independent [idcn] 0.0042519692977
Study [mnob] 0.00840123200086
Mortality [qnco] 0.00378791484737
DIAGNOSIS [fndg] 0.00397197468302
Conclusions [idcn] 0.00242100105895
Pathology [bmod] 0.0030963103863
Nonalcoholic Fatty Liver Disease [dsyn] 0.0029746090856
Methods [inpr] 0.00539656439294
Enhanced [acty] 0.00339312116374
Compared [acty] 0.00502973808782
liver resection [topp] 0.0034662036176
Including [ftcn] 0.00241690383458
YEARS [tmco] 0.00394264485497
LOWER [spco] 0.00258761791789
Cholangiocarcinoma [neop] 0.0024169900948
Liver Transplantation [topp] 0.00241126960358
LIVER [bpoc] 0.00983987106523
Related [qlco] 0.00899667036633
treatment [ftcn] 0.00629674470732
CIRRHOSIS [dsyn] 0.0105091819248
Levels [qlco] 0.00383359302456
Risk Factors [qnco] 0.0108601657169
LIVER DISEASE [dsyn] 0.00363888676684
TIME [tmco] 0.00350398731959
Increased [qnco] 0.00589667981077
HCC [neop] 0.00466533297892
topic6
Metastasis [neop] 0.0030368069997
Important [qlco] 0.00261709225349
Cells [cell] 0.00333026016293
Higher [qlco] 0.00306532551885
Including [ftcn] 0.00397352284102
Survival [acty] 0.00537680240257
Group [idcn] 0.0106275068758
Mechanisms [ftcn] 0.00329733819601
CI [geoa] 0.00273049978103
Hazard Ratio [qnco] 0.00247973516646
Mice [mamm] 0.00293271630212
HEPATITIS B VIRUS [virs] 0.00563371436822
Suggest [idcn] 0.00339552758294
Invasion [fndg] 0.00315655451004
Study [mnob] 0.00933059785379
control [qlco] 0.00292545218733
Independent [idcn] 0.00250926024827
Nonalcoholic Fatty Liver Disease [dsyn] 0.00361883752784
Methods [inpr] 0.00472213772025
Compared [acty] 0.00571016637798
Cases [ftcn] 0.00415290855317
YEARS [tmco] 0.00257793865794
Genes [gngm] 0.00267528527131
Cholangiocarcinoma [neop] 0.00465418822155
PORTAL VEIN [bpoc] 0.00275204034211
YEAR [tmco] 0.00283105894488
LIVER [bpoc] 0.0106050607191
Related [qlco] 0.00285395906715
Genotype [orga] 0.00357938950546
CCA [cgab] 0.00599142840972
Groups [idcn] 0.00260383907311
Odds Ratio [qnco] 0.0027368583579
treatment [ftcn] 0.00298046234797
Effects [qlco] 0.00359152175189
Risk Factors [qnco] 0.00542807656177
Pathology [bmod] 0.00423443773706
Based [ftcn] 0.0025485253911
CANCER [neop] 0.00587713726402
Median [spco] 0.00295526885667
Increased [qnco] 0.00348385204184
topic7
Important [qlco] 0.00326266588741
FIB [gngm] 0.00425288426628
Present [qnco] 0.00268537482233
Groups [idcn] 0.0026636816894
Complications [patf] 0.00347574538026
Group [idcn] 0.00562744972903
Based [ftcn] 0.00282932379603
CI [geoa] 0.00262992820361
Laparoscopic [diap] 0.00394260009191
Hazard Ratio [qnco] 0.00474598069004
HEPATITIS C VIRUS [virs] 0.00321847314262
Hepatectomy [topp] 0.00921422233582
Performed [ftcn] 0.00422450592908
HEPATITIS B VIRUS [virs] 0.0024779890689
Independent [idcn] 0.00329948596307
Study [mnob] 0.0115092155484
included [ftcn] 0.00291336834471
Nonalcoholic Fatty Liver Disease [dsyn] 0.0115320113711
Methods [inpr] 0.00474890064624
Compared [acty] 0.0043073553461
Cases [ftcn] 0.00428046160682
YEARS [tmco] 0.00490371603646
Index [inpr] 0.00327713764935
Cholangiocarcinoma [neop] 0.009518065133
LIVER [bpoc] 0.00491394495206
Related [qlco] 0.00251013281637
Genotype [orga] 0.00281175671645
CCA [cgab] 0.00341785163943
Following [tmco] 0.00251032031844
Postoperative [tmco] 0.00319194501729
Identified [qlco] 0.00403690844872
treatment [ftcn] 0.00326332701762
CIRRHOSIS [dsyn] 0.00305277412959
Survival [acty] 0.0074866945139
Preoperative [tmco] 0.00327854836716
Levels [qlco] 0.0025393118144
Risk Factors [qnco] 0.00987231183182
Association [menp] 0.00275403323583
CANCER [neop] 0.00286934280364
Increased [qnco] 0.00436240480859
topic8
Tumour NOS [neop] 0.00706603545172
Treated [ftcn] 0.00469276773357
Higher [qlco] 0.00336486045701
bile leakage [patf] 0.00366061970662
Including [ftcn] 0.00274687020133
Survival [acty] 0.00890456362386
Group [idcn] 0.00643707260439
resection [topp] 0.00504555658154
Based [ftcn] 0.00523566253869
HEPATITIS C VIRUS [virs] 0.00266249233808
Hazard Ratio [qnco] 0.00520717995138
Invasion [fndg] 0.00306327598961
LIVER [bpoc] 0.0132529245913
Performed [ftcn] 0.00293393031148
HEPATITIS B VIRUS [virs] 0.00260013003386
SUSTAINED VIROLOGIC RESPONSE [fndg] 0.00510609316678
Independent [idcn] 0.00466972781748
Related [qlco] 0.00579514984795
Study [mnob] 0.00844523757399
Mortality [qnco] 0.00327650471759
Conclusions [idcn] 0.00304578331998
Low [qlco] 0.00296180026093
Nonalcoholic Fatty Liver Disease [dsyn] 0.00515477170982
FIBROSIS [patf] 0.0057916029094
Compared [acty] 0.00341523393702
Cases [ftcn] 0.00625519075285
YEARS [tmco] 0.00448130618592
therapy [ftcn] 0.00261135446672
Liver Transplantation [topp] 0.0026861721437
Stage [tmco] 0.00280758877658
Hepatectomy [topp] 0.00458255782815
RATIO [qnco] 0.00279758508722
Advanced [qlco] 0.00449714806051
Postoperative [tmco] 0.00369707221956
Identified [qlco] 0.00507127062587
treatment [ftcn] 0.00725519400801
CIRRHOSIS [dsyn] 0.00692060589387
Levels [qlco] 0.00349386806688
Risk Factors [qnco] 0.00859107424941
Increased [qnco] 0.00299721414608
topic9
Tumour NOS [neop] 0.00392780856779
Higher [qlco] 0.00272573860014
Groups [idcn] 0.00279600197048
Survival [acty] 0.00357010629358
Group [idcn] 0.00610171538599
Including [ftcn] 0.003100112832
HEPATITIS C VIRUS [virs] 0.00307325197596
Nonalcoholic Steatohepatitis [dsyn] 0.00333786398245
Hepatic [blor] 0.00376279320045
Performed [ftcn] 0.00284289370363
Tumour thrombus [dsyn] 0.00275181121358
DIAGNOSIS [fndg] 0.00379359893751
Study [mnob] 0.00541905031083
Mortality [qnco] 0.00360528003683
surveillance [ftcn] 0.00419513521286
ULTRASOUND [diap] 0.00701198119531
Nonalcoholic Fatty Liver Disease [dsyn] 0.0075542776966
Methods [inpr] 0.00408280567482
Enhanced [acty] 0.0084358820304
Compared [acty] 0.00466524570391
Cases [ftcn] 0.00798880570294
YEARS [tmco] 0.0032164754086
Contrast [irda] 0.00601210137988
PORTAL VEIN [bpoc] 0.00611791625116
LIVER [bpoc] 0.0057580031208
Conclusions [idcn] 0.00288421770562
Related [qlco] 0.00286757025971
Evaluate [hlca] 0.00289990779545
Progression [patf] 0.00287564563766
Odds Ratio [qnco] 0.00304821154154
treatment [ftcn] 0.00300206027049
CIRRHOSIS [dsyn] 0.00504440534392
FIBROSIS [patf] 0.00507532075265
Preoperative [tmco] 0.0049329721877
Criteria [inpr] 0.00265954896198
Fibrosis, Liver [dsyn] 0.0032209288745
Risk Factors [qnco] 0.00544277550106
TIME [tmco] 0.00359539367846
Median [spco] 0.00267364634016
Increased [qnco] 0.00356934565745
